What is Merkel cell carcinoma? This rare form of skin cancer killed Jimmy Buffett after a 4-year battle
Jimmy Buffett died after a four-year battle with Merkel cell carcinoma. DM.com answers questions about it --what it is, how it wreaks havoc on the body, and what causes it. (Source: the Mail online | Health)
Source: the Mail online | Health - September 4, 2023 Category: Consumer Health News Source Type: news
Merkel Cell Carcinoma: What To Know About The Skin Cancer That Killed Jimmy Buffett
Vacation extraordinaire and topical rockstar Jimmy Buffett died Friday night from an aggressive form of skin cancer called Merkel cell carcinoma, a rare disease that impacts only one in 130,000 Americans each year and is often caused by exposure to the sun. Buffett, 76, had been fighting Merkel…#jimmybuffett #longisland #baptisthealth #margaritaville #big8 #kneedeep #zacbrown #rhodeisland #brigham #boston (Source: Reuters: Health)
Source: Reuters: Health - September 3, 2023 Category: Consumer Health News Source Type: news
Making One Key Connection May Increase HPV Vax Uptake Making One Key Connection May Increase HPV Vax Uptake
Most of the 288 adults surveyed were not aware that HPV causes oropharyngeal squamous cell carcinoma and had not been told of the relationship by their healthcare provider.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 1, 2023 Category: Cancer & Oncology Tags: Infectious Diseases News Source Type: news
DBT-detected lobular neoplasia shows low upgrade rate
Surveillance could be a preferred management strategy for lobular neoplasi...Read more on AuntMinnie.comRelated Reading:
Breast MRI uptake is low among women at high breast cancer risk
Abbreviated MRI shows promise, CEM has tradeoffs in breast imaging
AI shows perfect performance in invasive lobular carcinoma
CEM on par with breast MRI in lobular breast cancer staging
SBI: The presence of LCIS indicates increased breast cancer risk (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 31, 2023 Category: Radiology Source Type: news
Novel Biomarker Boosts Diagnostic Accuracy of Nasopharyngeal Cancer Screening
(MedPage Today) -- A novel biomarker derived from Epstein-Barr virus (EBV) significantly improved the diagnostic accuracy for nasopharyngeal carcinoma, a large screening study from China showed.
Screening with P85-Ab, an anti-BNLF2b total antibody... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 30, 2023 Category: Hematology Source Type: news
Urine Test Shows Promise for Diagnosing Urothelial Carcinoma Urine Test Shows Promise for Diagnosing Urothelial Carcinoma
A validation study found that a simple urine test can accurately diagnose urothelial carcinoma and predict a patients ' risk for recurrence.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 29, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Roche ’s Tecentriq becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Great Britain, reducing treatment time to just minutes
Tecentriq subcutaneous (SC) is now approved in Great Britain for all indications of intravenousTecentriq, including certain types of lung, bladder, breast and liver cancer, offering a faster, more convenient option to receive treatmentAdministered under the skin within approx. seven minutes,Tecentriq SC saves time for patients and helps conserve resources in healthcare systems1Evaluations by the FDA, EMA and other health authorities globally are ongoingBasel, 29 August 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Tecentriq ® SC (atezolizumab) has been approved by the Medicines and Healthcare products Reg...
Source: Roche Investor Update - August 29, 2023 Category: Pharmaceuticals Source Type: news
Roche ’s Tecentriq becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Great Britain, reducing treatment time to just minutes
Tecentriq subcutaneous (SC) is now approved in Great Britain for all indications of intravenousTecentriq, including certain types of lung, bladder, breast and liver cancer, offering a faster, more convenient option to receive treatmentAdministered under the skin within approx. seven minutes,Tecentriq SC saves time for patients and helps conserve resources in healthcare systems1Evaluations by the FDA, EMA and other health authorities globally are ongoingBasel, 29 August 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Tecentriq ® SC (atezolizumab) has been approved by the Medicines and Healthcare products Reg...
Source: Roche Media News - August 29, 2023 Category: Pharmaceuticals Source Type: news
Mohs Found to Confer Survival Benefit in Localized MCC Mohs Found to Confer Survival Benefit in Localized MCC
Mohs micrographic surgery may be more effective than wide local excision as a surgical treatment for localized T1/T2 Merkel cell carcinoma.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 24, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Mohs Surgery Best for Early-Stage Merkel Cell Carcinoma?
(MedPage Today) -- Mohs micrographic surgery may offer a survival advantage over wide local excision for select patients with early-stage Merkel cell carcinoma (MCC), a retrospective cohort study suggested.
Over a mean follow-up of about 5 years... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - August 23, 2023 Category: Surgery Source Type: news
Ultrasound-guided magnetic seeds localize breast lesions
Ultrasound-guided localization with magnetic seeds can localize nonpalpabl...Read more on AuntMinnie.comRelated Reading:
AI model distinguishes luminal, nonluminal breast cancers
AI model helps improve breast ultrasound interpretation
CAD improves radiologists' breast ultrasound reading performance
AI shows perfect performance in invasive lobular carcinoma
SBI: Supplemental screening key to finding interval breast cancers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 23, 2023 Category: Radiology Source Type: news
Protean BioDiagnostics Partners with Travera to Support Advanced Carcinoma Patients and Their Physicians
Protean BioDiagnostics to enhance its current offering of advanced diagnostic services as a Travera Center of Excellence. Travera's Rapid Therapy Guidance testing for patients with advanced carcinomas can help determine their cancer's response to specific drugs. MEDFORD, Mass., Aug. 22,... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 22, 2023 Category: Pharmaceuticals Tags: LIC Source Type: news
AI Pipeline Can Accurately Measure Sarcopenia in Head and Neck Cancer
MONDAY, Aug. 14, 2023 -- A fully automated deep learning pipeline can accurately measure sarcopenia in head and neck squamous cell carcinoma (HNSCC), which is associated with disease outcomes, according to a study published online Aug. 10 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 14, 2023 Category: Pharmaceuticals Source Type: news
Ray Trapp: Build resilience to meet life's challenges
13 months from the diagnosis of stage three renal cell carcinoma and I sit here in awe of the audacity of resilience. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 13, 2023 Category: Pharmaceuticals Authors: Ray Trapp Source Type: news
More Intensive Imaging Follow-Up in Head, Neck Cancer? More Intensive Imaging Follow-Up in Head, Neck Cancer?
Patients with advanced head and neck squamous cell carcinoma demonstrated improved overall survival with intensive post-treatment follow-up monitoring with 18F- FDG-PET/CT vs conventional follow-up.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 11, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
